Combination therapy of a type II antiCD20 antibody with an anti-Bcl-2 active agent

Details for Australian Patent Application No. 2008314068 (hide)

Owner F. Hoffmann-La Roche AG Roche Glycart AG

Inventors Friess, Thomas; Klein, Christian; Umana, Pablo; Braemer, Pamela

Agent Davies Collison Cave

Pub. Number AU-A-2008314068

PCT Pub. Number WO2009/049841

Priority 07020120.7 15.10.07 EP

Filing date 13 October 2008

Wipo publication date 23 April 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

22 April 2010 PCT application entered the National Phase

  PCT publication WO2009/049841 Priority application(s): WO2009/049841

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008314078-Spiroheterocyclic pyrrolidine dione derivatives useful as pesticides

2008314055-Lock device and method for opening the lock device